Is it growing?
Is COLL growing?
Collegium Pharmaceutical, Inc. has grown revenue 15% a year over three years and 20% a year over five.
+15%
Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +15% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue
- Revenue growth, 5-year rate
- +20%
Revenue growth, 5-year rate · +15% over three · growth has slowed since the five-year average
- Years of annual history on file
- 13
Years of annual history on file · FY2013 to FY2025, as filed
Details›
- Revenue FY2021
- $277M
- Revenue FY2022
- $464M
- Revenue FY2023
- $567M
- Revenue FY2024
- $631M
- Revenue FY2025
- $781M
Annual income statements as filed with the SEC.
Drug Manufacturers - Specialty & Generic
Ranks #13 of 28 by Smart Score